Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Capital Expenditures: 2020-2025

Historic Capital Expenditures for IM Cannabis (IMCC) over the last 5 years, with Sep 2025 value amounting to -$2,906.

  • IM Cannabis' Capital Expenditures rose 94.64% to -$2,906 in Q3 2025 from the same period last year, while for Sep 2025 it was $108,161, marking a year-over-year decrease of 85.40%. This contributed to the annual value of $113,942 for FY2024, which is 73.54% down from last year.
  • According to the latest figures from Q3 2025, IM Cannabis' Capital Expenditures is -$2,906, which was down 101.44% from $201,869 recorded in Q4 2024.
  • IM Cannabis' 5-year Capital Expenditures high stood at $6.2 million for Q4 2021, and its period low was -$1.1 million during Q3 2021.
  • Moreover, its 3-year median value for Capital Expenditures was -$19,731 (2025), whereas its average is $66,239.
  • In the last 5 years, IM Cannabis' Capital Expenditures slumped by 211.36% in 2021 and then soared by 99.51% in 2024.
  • IM Cannabis' Capital Expenditures (Quarterly) stood at $6.2 million in 2021, then tumbled by 64.73% to $2.2 million in 2022, then slumped by 61.66% to $832,963 in 2023, then crashed by 75.76% to $201,869 in 2024, then surged by 94.64% to -$2,906 in 2025.
  • Its last three reported values are -$2,906 in Q3 2025, $201,869 for Q4 2024, and -$54,246 during Q3 2024.